Mice with an isoform-ablating Mecp2exon 1 mutation recapitulate the neurologic deficits of Rett syndrome

Human Molecular Genetics

Volumn 23, Issue 9, 2014, Pages 2447-2458

  Yasui, Dag H ^a   Gonzales, Michael L ^b   Aflatooni, Justin O ^a   Crary, Florence K ^a   Hu, Daniel J ^a   Gavino, Bryant J ^a   Golub, Mari S ^a,c   Vincent, John B ^d   Schanen, N Carolyn ^e,f   Olson, Carl O ^g   Rastegar, Mojgan ^g   Lasalle, Janine M ^a,h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FLUIDIGM CORPORATION   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e UNIVERSITY OF DELAWARE   (United States)

^f NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^g UNIVERSITY OF MANITOBA   (Canada)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2; METHYL CPG BINDING PROTEIN 2 E1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR DISORDER; BRAIN NERVE CELL; CELL NUCLEUS MATRIX; CONTROLLED STUDY; EMBRYO; EXON; FEMALE; FORELIMB; GENE DELETION; GENE MUTATION; GENETIC ENGINEERING; GERM LINE; GROOMING; HINDLIMB; KNOCKOUT MOUSE; MALE; MASS SPECTROMETRY; MECP2 GENE; MOUSE; MOUSE MODEL; MUTATIONAL ANALYSIS; NONHUMAN; PHYSICAL ACTIVITY; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; RETT SYNDROME; RUNNING; SITE DIRECTED MUTAGENESIS; SOCIAL BEHAVIOR; START CODON; STEREOTYPY; WESTERN BLOTTING; ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; MUTATION; TRANSGENIC MOUSE;

ANIMALS; BLOTTING, WESTERN; EXONS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, TRANSGENIC; MUTATION; RETT SYNDROME;

EID: 84896978613     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt640     Document Type: Article

References (41)

1. Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U. and Zoghbi, H.Y. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet., 23, 185-188.
2. Coy, J.F., Sedlacek, Z., Bachner, D., Delius, H. and Poustka, A. (1999) A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3''-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression. Hum. Mol. Genet., 8, 1253-1262.
3. Kriaucionis, S. and Bird, A. (2004) The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res., 32, 1818-1823.
4. Mnatzakanian, G.N., Lohi, H., Munteanu, I., Alfred, S.E., Yamada, T., MacLeod, P.J., Jones, J.R., Scherer, S.W., Schanen, N.C., Friez, M.J. et al. (2004) A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat. Genet., 36, 339-341.
5. Zachariah, R.M., Olson, C.O., Ezeonwuka, C. and Rastegar, M. (2012) Novel MeCP2 isoform-specific antibody reveals the endogenous MeCP2E1 expression in murine brain, primary neurons and astrocytes. PloS ONE, 7, e49763.
6. Amir, R.E., Fang, P., Yu, Z., Glaze, D.G., Percy, A.K., Zoghbi, H.Y., Roa, B.B. and Van den Veyver, I.B. (2005) Mutations in exon 1 of MECP2 are a rare cause of Rett syndrome. J. Med. Genet., 42, e15.
7. Quenard, A., Yilmaz, S., Fontaine, H., Bienvenu, T., Moncla, A., des Portes, V., Rivier, F., Mathieu, M., Raux, G., Jonveaux, P. et al. (2006) Deleterious mutations in exon 1 of MECP2 in Rett syndrome. Eur. J. Med. Genet., 49, 313-322.
8. Saunders, C.J., Minassian, B.E., Chow, E.W., Zhao, W. and Vincent, J.B. (2009) Novel exon 1 mutations in MECP2 implicate isoform MeCP2_e1 in classical Rett syndrome. Am. J. Med. Genet A., 149A, 1019-1023.
9. Guy, J., Hendrich, B., Holmes, M., Martin, J.E. and Bird, A. (2001)Amouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet., 27, 322-326.
10. Chen, R.Z., Akbarian, S., Tudor, M. and Jaenisch, R. (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet., 27, 327-331.
11. Pelka, G.J., Watson, C.M., Radziewic, T., Hayward, M., Lahooti, H., Christodoulou, J. and Tam, P.P. (2006) Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain, 129, 887-898.
12. Itoh, M., Tahimic, C.G., Ide, S., Otsuki, A., Sasaoka, T., Noguchi, S., Oshimura, M., Goto, Y. and Kurimasa, A. (2012) Methyl CpG-binding protein isoform MeCP2-e2 is dispensable for Rett syndrome phenotypes but essential for embryo viability and placenta development. J. Biol. Chem., 287, 13859-13867.
13. Gianakopoulos, P.J., Zhang, Y., Pencea, N., Orlic-Milacic, M., Mittal, K., Windpassinger, C., White, S.J., Kroisel, P.M., Chow, E.W., Saunders, C.J. et al. (2012) Mutations in MECP2 exon 1 in classical Rett patients disrupt MECP2_e1 transcription, but not transcription of MECP2_e2. Am. J. Med. Genet. B Neuropsychiatr. Genet., 159B, 210-216.
14. Shahbazian, M., Young, J., Yuva-Paylor, L., Spencer, C., Antalffy, B., Noebels, J., Armstrong, D., Paylor, R. and Zoghbi, H. (2002) Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron, 35, 243-254.
15. Goffin, D., Allen, M., Zhang, L., Amorim, M., Wang, I.T., Reyes, A.R., Mercado-Berton, A., Ong, C., Cohen, S., Hu, L. et al. (2011) Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses. Nat. Neurosci., 15, 274-283.
16. Chahrour, M. and Zoghbi, H.Y. (2007) The story of Rett syndrome: from clinic to neurobiology. Neuron, 56, 422-437.
17. Rastegar, M., Hotta, A., Pasceri, P., Makarem, M., Cheung, A.Y., Elliott, S., Park, K.J., Adachi, M., Jones, F.S., Clarke, I.D. et al. (2009) MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy. PloS ONE, 4, e6810.
18. Kerr, B., Soto, C.J., Saez, M., Abrams, A., Walz, K. and Young, J.I. (2012) Transgenic complementation of MeCP2 deficiency: phenotypic rescue of Mecp2-null mice by isoform-specific transgenes. Eur. J. Hum. Genet., 20, 69-76.
19. Kumar, A., Kamboj, S., Malone, B.M., Kudo, S., Twiss, J.L., Czymmek, K.J., LaSalle, J.M. and Schanen, N.C. (2008) Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated proteinMECP2in vivo. J. Cell Sci., 121, 1128-1137.
20. Gonzales, M.L., Adams, S., Dunaway, K.W. and LaSalle, J.M. (2012) Phosphorylation of distinct sites in MeCP2 modifies cofactor associations and the dynamics of transcriptional regulation. Mol. Cell. Biol., 32, 2894-2903.
21. Nan, X., Campoy, F.J. and Bird, A. (1997) MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell, 88, 471-481.
22. Brero, A., Easwaran, H.P., Nowak, D., Grunewald, I., Cremer, T., Leonhardt, H. and Cardoso, M.C. (2005) Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation. J. Cell. Biol., 169, 733-743.
23. Salton, M., Lerenthal, Y., Wang, S.Y., Chen, D.J. and Shiloh, Y. (2010) Involvement of Matrin 3 and SFPQ/NONO in the DNA damage response. Cell Cycle, 9, 1568-1576.
24. Malyavantham, K.S., Bhattacharya, S., Barbeitos, M., Mukherjee, L., Xu, J., Fackelmayer, F.O. and Berezney, R. (2008) Identifying functional neighborhoods within the cell nucleus: proximity analysis of early S-phase replicating chromatin domains to sites of transcription, RNA polymerase II, HP1gamma, matrin 3 and SAF-A. J. Cell. Biochem., 105, 391-403.
25. Berezney, R., Mortillaro, M.J., Ma, H., Wei, X. and Samarabandu, J. (1995) The nuclear matrix: a structural milieu for genomic function. Int. Rev. Cytol., 162A, 1-65.
26. Small, D., Nelkin, B. and Vogelstein, B. (1982) Nonrandom distribution of repeated DNA sequences with respect to supercoiled loops and the nuclear matrix. Proc. Natl. Acad. Sci. USA, 79, 5911-5915.
27. Malyavantham, K.S., Bhattacharya, S., Alonso, W.D., Acharya, R. and Berezney, R. (2008) Spatio-temporal dynamics of replication and transcription sites in the mammalian cell nucleus. Chromosoma, 117, 553-567.
28. Yasui, D., Miyano, M., Cai, S., Varga-Weisz, P. and Kohwi-Shigematsu, T. (2002) SATB1 targets chromatin remodelling to regulate genes over long distances. Nature, 419, 641-645.
29. Young, J.I., Hong, E.P., Castle, J.C., Crespo-Barreto, J., Bowman, A.B., Rose, M.F., Kang, D., Richman, R., Johnson, J.M., Berget, S. et al. (2005) Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc. Natl. Acad. Sci. USA, 102, 17551-17558.
30. Chandler, S.P., Guschin, D., Landsberger, N. and Wolffe, A.P. (1999) The methyl-CpGbinding transcriptional repressorMeCP2stably associates with nucleosomal DNA. Biochemistry, 38, 7008-7018.
31. Gadalla, K.K., Bailey, M.E., Spike, R.C., Ross, P.D., Woodard, K.T., Kalburgi, S.N., Bachaboina, L., Deng, J.V., West, A.E., Samulski, R.J. et al. (2013) Improved survival and reduced phenotypic severity following AAV9/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice. Mol. Ther., 21, 18-30.
32. Luikenhuis, S., Giacometti, E., Beard, C.F. and Jaenisch, R. (2004) Expression ofMeCP2in postmitotic neurons rescues Rett syndrome in mice. Proc. Natl. Acad. Sci. USA, 101, 6033-6038.
33. Giacometti, E., Luikenhuis, S., Beard, C. and Jaenisch, R. (2007) Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc. Natl. Acad. Sci. USA, 104, 1931-1936.
34. Samaco, R.C., Fryer, J.D., Ren, J., Fyffe, S., Chao, H.T., Sun, Y., Greer, J.J., Zoghbi, H.Y. and Neul, J.L. (2008) A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome. Hum. Mol. Genet., 17, 1718-1727.
35. Kerr, B., Alvarez-Saavedra, M., Saez, M.A., Saona, A. and Young, J.I. (2008) Defective body-weight regulation, motor control and abnormal social interactions in Mecp2 hypomorphic mice. Hum. Mol. Genet., 17, 1707-1717.
36. Maunakea, A.K., Chepelev, I., Cui, K. and Zhao, K. (2013) IntragenicDNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition. Cell Res., 23, 1256-1269.
37. Dignam, J.D., Lebovitz, R.M. and Roeder, R.G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11, 1475-1489.
38. Guy, J., Gan, J., Selfridge, J., Cobb, S. and Bird, A. (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science, 315, 1143-1147.
39. Woods, R., Vallero, R.O., Golub, M.S., Suarez, J.K., Ta, T.A., Yasui, D.H., Chi, L.H., Kostyniak, P.J., Pessah, I.N., Berman, R.F. et al. (2012) Long-lived epigenetic interactions between perinatal PBDE exposure and Mecp2308 mutation. Hum. Mol. Genet., 21, 2399-2411.
40. Moy, S.S., Nadler, J.J., Perez, A., Barbaro, R.P., Johns, J.M., Magnuson, T.R., Piven, J. and Crawley, J.N. (2004) Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav., 3, 287-302.
41. Golub, M.S., Germann, S.L., Araiza, R.S., Reader, J.R., Griffey, S.M. and Lloyd, K.C. (2005) Movement disorders in the Hfe knockout mouse. Nutr. Neurosci., 8, 239-244. 2458 Human Molecular Genetics, 2014, Vol. 23, No. 9